| Biology of incretins: GLP-1 and GIP LL Baggio, DJ Drucker Gastroenterology 132 (6), 2131-2157, 2007 | 4549 | 2007 |
| Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells H Ellingsgaard, I Hauselmann, B Schuler, AM Habib, LL Baggio, DT Meier, ... Nature medicine 17 (11), 1481-1489, 2011 | 1067 | 2011 |
| Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 D Marguet, L Baggio, T Kobayashi, AM Bernard, M Pierres, PF Nielsen, ... Proceedings of the National Academy of Sciences 97 (12), 6874-6879, 2000 | 719 | 2000 |
| GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice MH Noyan-Ashraf, MA Momen, K Ban, AM Sadi, YQ Zhou, AM Riazi, ... Diabetes 58 (4), 975-983, 2009 | 718 | 2009 |
| Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons H Yamamoto, CE Lee, JN Marcus, TD Williams, JM Overton, ME Lopez, ... The Journal of clinical investigation 110 (1), 43-52, 2002 | 613 | 2002 |
| GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress B Yusta, LL Baggio, JL Estall, JA Koehler, DP Holland, H Li, D Pipeleers, ... Cell metabolism 4 (5), 391-406, 2006 | 584 | 2006 |
| A recombinant human glucagon-like peptide (GLP)-1–albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor–dependent pathways coupled with satiety … LL Baggio, Q Huang, TJ Brown, DJ Drucker Diabetes 53 (9), 2492-2500, 2004 | 498 | 2004 |
| Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure LL Baggio, Q Huang, TJ Brown, DJ Drucker Gastroenterology 127 (2), 546-558, 2004 | 469 | 2004 |
| Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors T Hansotia, LL Baggio, D Delmeire, SA Hinke, Y Yamada, K Tsukiyama, ... Diabetes 53 (5), 1326-1335, 2004 | 380 | 2004 |
| GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice N Panjwani, EE Mulvihill, C Longuet, B Yusta, JE Campbell, TJ Brown, ... Endocrinology 154 (1), 127-139, 2013 | 378 | 2013 |
| The glucagon receptor is required for the adaptive metabolic response to fasting C Longuet, EM Sinclair, A Maida, LL Baggio, M Maziarz, MJ Charron, ... Cell metabolism 8 (5), 359-371, 2008 | 312 | 2008 |
| Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo JG Kim, LL Baggio, DP Bridon, JP Castaigne, MF Robitaille, L Jetté, ... Diabetes 52 (3), 751-759, 2003 | 300 | 2003 |
| Cardiac function in mice lacking the glucagon-like peptide-1 receptor R Gros, X You, LL Baggio, MG Kabir, AM Sadi, IN Mungrue, TG Parker, ... Endocrinology 144 (6), 2242-2252, 2003 | 282 | 2003 |
| GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R B Yusta, LL Baggio, J Koehler, D Holland, X Cao, LJ Pinnell, ... Diabetes 64 (7), 2537-2549, 2015 | 243 | 2015 |
| Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease LL Baggio, DJ Drucker Molecular metabolism 46, 101090, 2021 | 240 | 2021 |
| GLP-1 receptor expression within the human heart LL Baggio, B Yusta, EE Mulvihill, X Cao, CJ Streutker, J Butany, ... Endocrinology 159 (4), 1570-1584, 2018 | 239 | 2018 |
| Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight LL Baggio, DJ Drucker The Journal of clinical investigation 124 (10), 4223-4226, 2014 | 221 | 2014 |
| Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice JA Koehler, LL Baggio, BJ Lamont, S Ali, DJ Drucker diabetes 58 (9), 2148-2161, 2009 | 204 | 2009 |
| Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice G Flock, LL Baggio, C Longuet, DJ Drucker Diabetes 56 (12), 3006-3013, 2007 | 196 | 2007 |
| Therapeutic approaches to preserve islet mass in type 2 diabetes LL Baggio, DJ Drucker Annu. Rev. Med. 57 (1), 265-281, 2006 | 194 | 2006 |